Development of NVX-CoV2373 vaccine against new coronavirus
- Funded by Japan Agency for Medical Research and Development (AMED)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Japan Agency for Medical Research and Development (AMED)Principal Investigator
Mitsuhiro MoriResearch Location
JapanLead Research Institution
Takeda Pharmaceutical Company LimitedResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable